Home/Filings/4/0001824293-23-000163
4//SEC Filing

Kelly Leanne 4

Accession 0001824293-23-000163

CIK 0001824293other

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 4:08 PM ET

Size

5.6 KB

Accession

0001824293-23-000163

Insider Transaction Report

Form 4
Period: 2023-09-22
Kelly Leanne
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-22$1.52/sh+83,333$126,66683,333 total
    Exercise: $1.52Exp: 2033-09-22Common Stock (83,333 underlying)
Footnotes (1)
  • [F1]Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 36 equal monthly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.

Issuer

GRI BIO, Inc.

CIK 0001824293

Entity typeother

Related Parties

1
  • filerCIK 0001398278

Filing Metadata

Form type
4
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 4:08 PM ET
Size
5.6 KB